HBx facilitates drug resistance in hepatocellular carcinoma via CD133-regulated self-renewal of liver cancer stem cells
2024-12-10
(Press-News.org) Background and Aims
Hepatitis B virus (HBV) infection contributes to hepatocellular carcinoma (HCC) tumorigenesis, drug resistance, and recurrence, although the underlying molecular mechanisms remain unclear. Recent studies suggest that HBV infection may be associated with liver cancer stem cells (LCSCs), but the exact mechanisms are yet to be resolved. In this study, we aimed to analyze the role of HBV infection in regulating the stemness of HCCs, which is closely linked to drug resistance.
Methods
Sphere formation assay and real-time Polymerase Chain Reaction quantification were used to isolate and confirm liver cancer stem cells. The inhibitory concentration values of sorafenib and regorafenib were calculated and compared using the Cell Counting Kit-8 assay. HBV infection was used to assess the effect of HBV replication on LCSC markers. Co-immunoprecipitation assay was performed to detect the interaction between CD133 and SRC. Furthermore, we utilized the CRISPR-Cas9 system to knockout CD133 expression in HepG2.2.15 cells.
Results
LCSCs derived from HCCs exhibited high expression of stem cell markers and demonstrated reduced sensitivity to sorafenib and regorafenib. HBV replication promoted both drug resistance and stemness in hepatoma cells and clinical samples. Overexpression of HBx protein in HepG2 cells upregulated the expression of CD133, EpCAM, and CD24, enhancing resistance to sorafenib and regorafenib. Knockout of CD133 expression using the CRISPR-Cas9 system significantly inhibited drug resistance to both sorafenib and regorafenib in HepG2.2.15 cells. Mechanistically, HBV replication promoted CD133 expression, which in turn interacted with the SRC/STAT3 signaling pathway.
Conclusions
Our data suggest that HBV replication enhances the stemness and drug resistance of HCC, providing a strong theoretical foundation for the development of targeted and efficient treatments for HBV-infected HCCs.
Full text
https://www.xiahepublishing.com/2310-8819/JCTH-2024-00259
The study was recently published in the Journal of Clinical and Translational Hepatology.
The Journal of Clinical and Translational Hepatology (JCTH) is owned by the Second Affiliated Hospital of Chongqing Medical University and published by XIA & HE Publishing Inc. JCTH publishes high quality, peer reviewed studies in the translational and clinical human health sciences of liver diseases. JCTH has established high standards for publication of original research, which are characterized by a study’s novelty, quality, and ethical conduct in the scientific process as well as in the communication of the research findings. Each issue includes articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field. Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases. Regular features of JCTH also include editorials, correspondences and invited commentaries on rapidly progressing areas in hepatology. All articles published by JCTH, both solicited and unsolicited, must pass our rigorous peer review process.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-12-10
Rockville, MD – December 10, 2024 –The American Society for Nutrition (ASN) applauds the release of the Scientific Report of the 2025 Dietary Guidelines Advisory Committee (DGAC). The Society is pleased to note that 19 of the 20 Committee members are ASN members, including the Chair, ASN President Sarah Booth, and Vice Chair, Angela Odoms-Young, a member of the ASN Board of Directors. The DGAC is an independent panel of nutrition science experts tasked to review the state of the evidence on nutrition-related topics and scientific questions identified by the U.S. Department of Agriculture (USDA) ...
2024-12-10
OAK BROOK, Ill. – The number of women with late-stage, invasive breast cancer at the time of diagnosis increased significantly among U.S. women across all ages and ethnicities between 2004 and 2021, according to a study published today in Radiology, a journal of the Radiological Society of North America (RSNA).
In the study, researchers analyzed the latest available Surveillance, Epidemiology, and End Results (SEER) data on annual stage-specific breast cancer incidence rates between 2004 and 2021. SEER data is collected from 22 population-based ...
2024-12-10
OAK BROOK, Ill. – Researchers at the Yale School of Medicine found structural and functional alterations in specific brain regions of individuals with opioid use disorder. The study’s results were published today in Radiology, a journal of the Radiological Society of North America (RSNA).
Opioids are a class of drugs that include synthetic opioids such as fentanyl, prescription pain relievers like oxycodone, and illegal narcotics, including heroin. Opioids have a high potential for misuse, and opioid use is a major contributor to drug overdoses in the ...
2024-12-10
Media Contact:
John Dudley
(814) 490-3290 (cell)
jjdudley@usf.edu
EMBARGOED FOR PUBLICATION UNTIL TUESDAY, DEC. 10, AT 10 A.M. ET
TAMPA, Fla. (Embargoed until Dec. 10, 2024) – Colorectal cancer, the second leading cause of cancer-related deaths in the United States, may be fueled by the food on our plates. Researchers at the University of South Florida and Tampa General Hospital Cancer Institute have uncovered a potential link between the Western diet – dominated by ultra-processed foods and unhealthy oils – and the chronic inflammation that drives ...
2024-12-10
Polymer scientist Gary E. Wnek and stem-cell biologist Arnold Caplan have been named Fellows of the National Academy of Inventors (NAI), the highest professional distinction awarded solely to inventors.
The two Case Western Reserve University faculty members will be inducted June 26 at the NAI’s 14th annual conference in Atlanta. Caplan, who was nominated in 2023, died in January. The NAI said his family will be invited to accept the medal in his honor.
The NAI Fellows Program was established “to highlight academic ...
2024-12-10
UCSF scientists combine a precision drug therapy with an antibody and radiation to eliminate tumors without causing side effects.
Radiation is one of the most effective ways to kill a tumor. But these therapies are indiscriminate, and they can damage healthy tissues.
Now, UC San Francisco scientists have developed a way to deliver radiation just to cancerous cells. The therapy combines a drug to mark the cancer cells for destruction and a radioactive antibody to kill them.
It wiped out bladder and lung tumors in mice ...
2024-12-10
A massive cleanup of derelict fishing gear in U.S. coastal waters is set to begin now that William & Mary’s Batten School & VIMS has awarded $1.4 million to fund 11 projects under the National Fishing Trap Removal, Assessment, and Prevention (TRAP) Program. From diving in waters up to 130 feet deep to retrieve lobster and crab traps in protected ecosystems to the removal of debris in tribal fishing grounds, this initial round of projects facilitates removal efforts in California, Connecticut, Delaware, Florida, Louisiana, Maine, Maryland, ...
2024-12-10
MIAMI, FLORIDA (EMBARGOED UNTIL Dec. 10, 2024, AT 10AM EST) – New research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that one’s biological age, which can be higher than his or her chronological age – a concept called accelerated aging – may predict who’s at risk for developing colon polyps, a known risk factor for colorectal cancer.
The findings, published in Cancer Prevention Research, a journal of the American Association for Cancer Research, link accelerated aging to increased early colorectal cancer ...
2024-12-10
The National Academy of Inventors (NAI) announced today the election of 170 exceptional inventors into the 2024 Class of Fellows. NAI Fellowship is the highest professional distinction awarded solely to inventors. The full list of 2024 Fellows can be found here.
The 2024 cohort of Fellows exemplifies the Academy’s belief that groundbreaking innovation knows no bounds and inventors can be found everywhere. This is evident in the fact that the honorees represent 39 U.S. states, 12 countries, and 43% identify as underrepresented ...
2024-12-10
SAN ANTONIO — December 10, 2024 — Southwest Research Institute successfully customized and conducted a full-scale evaluation of a novel fire mitigation method designed to safely store damaged electric vehicles and batteries. SwRI engineers demonstrate customized research and development support for government and industry clients with novel projects and challenges related to emerging technologies where no standardized testing exists.
“SwRI established the nation’s first fire-focused research program 75 years ago, so our extensive ...
LAST 30 PRESS RELEASES:
[Press-News.org] HBx facilitates drug resistance in hepatocellular carcinoma via CD133-regulated self-renewal of liver cancer stem cells
